Imatinib (Addition) -- Adults
Drug information
Section 8: Antineoplastic, immunosuppressives and medicines used in palliative care 8.2: Cytotoxic and adjuvant medicines
Formulation:
Tablet (mesylte): 400 mg; 600 mg; 800 mg.
Application prepared by:
Weill Cornell / Rockefeller/ Sloan-Kettering, Tri-Institutional MD-PhD Program, 1230 York Avenue, Box 292, New York, New York 10065